| Income Statement |
| Total Revenue | 13.95M |
|
| Revenues (USD) | 13.95M |
| Cost of Revenue | 6.95M |
| Gross Profit | 7.00M |
| Operating Expenses | 7.06M |
| Research and Development Expense | 1.23M |
| Selling, General and Administrative Expense | 5.83M |
| Operating Income | -54.00K |
| Interest Expense | -59.00K |
| Income Tax Expense | 30.00K |
| Net Income | -50.00K |
| Net Income Common Stock | -50.00K |
| Net Income Common Stock (USD) | -50.00K |
| Consolidated Income | -50.00K |
| Earning Before Interest & Taxes (EBIT) | -79.00K |
| Earning Before Interest & Taxes (USD) | -79.00K |
| Weighted Average Shares | 10.29M |
| Weighted Average Shares Diluted | 10.29M |
| Balance Sheet |
| Cash and Equivalents | 19.39M |
| Cash and Equivalents (USD) | 19.39M |
| Trade and Non-Trade Receivables | 10.36M |
| Current Assets | 40.56M |
| Property, Plant & Equipment Net | 4.31M |
| Total Assets | 51.02M |
| Debt Current | 3.51M |
| Total Debt | 6.23M |
| Current Liabilities | 15.30M |
| Debt Non-Current | 2.72M |
| Total Liabilities | 18.35M |
| Accumulated Retained Earnings (Deficit) | 3.99M |
| Accumulated Other Comprehensive Income | -45.00K |
| Shareholders Equity | 32.67M |
| Shareholders Equity (USD) | 32.67M |
| Assets Non-Current | 10.46M |
| Total Debt (USD) | 6.23M |
| Deferred Revenue | 2.14M |
| Goodwill and Intangible Assets | 6.10M |
| Inventory | 9.09M |
| Liabilities Non-Current | 3.05M |
| Trade and Non-Trade Payables | 5.03M |
| Tax Assets | 424.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 138.00K |
| Net Cash Flow from Financing | -24.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 546.00K |
| Capital Expenditure | -1.55M |
| Net Cash Flow from Investing | -1.55M |
| Net Cash Flow from Operations | 2.15M |
| Effect of Exchange Rate Changes on Cash | -35.00K |
| Share Based Compensation | 455.00K |